Infectious Diarrhoea
Infection Infectious diarrhoea Brief outline/clinical setting Acute diarrhoea loose stools 3 or more /24hrs, watery or bloody (dysentery) Aetiologies/organisms Bacteria: Aeromonas spp , Bacillus cereus, Campylobacter spp , Clostridium difficile, Clostridium perfringens, Escherichia coli (EHEC, STEC, EIEC, EPEC) *, Listeria monocytogenes, Pleisiomonas shigelloides, Salmonella spp , Shigella spp ,
| Infection | Infectious diarrhoea |
|---|---|
| Brief outline/clinical setting | Acute diarrhoea loose stools 3 or more /24hrs, watery or bloody (dysentery) |
| Aetiologies/organisms | Bacteria: Aeromonas spp, Bacillus cereus, Campylobacter spp, Clostridium difficile, Clostridium perfringens, Escherichia coli (EHEC, STEC, EIEC, EPEC)*, Listeria monocytogenes, Pleisiomonas shigelloides, Salmonella spp, Shigella spp, Staphylococcus aureus, Vibrio spp, Yersinia enterocolitica and Yersinia pseudotuberculosis Viruses: Rotavirus, Adenovirus, Astrovirus, Human calicivirus, Norovirus, Sapovirus Parasites: Entamoeba histolytica, Giardia lamblia, Trichurius, Strongyloides, Schistosomiasis, Cryptosporidium, Cyclospora cayetanensis, Dientamoeba fragilis, Balantidium coli, Blastocystis spp, Cytoisospora belli, Hymenolepis nana/diminuta, Diphyllobothrium latum/nihonkaiense, Taenia solium, Taenia saginata/asiatica, Clonorchis sinensis/Opisthorchis spp./Metorchis spp, Fasciola hepatica/gigantica, Schistosoma mansoni, Schistosoma spp, Ancylostoma duodenale, Necator americanus, Ascaris lumbricoides/suum, Enterobius vermicularis, Strongyloides stercoralis, Trichuris spp., Enerocytozoon bieneusi, Encephalitozoon spp |
| Optimal antimicrobial selection |
Majority of acute diarrheal illness will not require antibiotic therapy
If recent hospitalization, institutionalization or antibiotic history C.difficile testing |
| Duration | Stat or 3 days |
| Alternative if allergic/not available | Azithromycin: 1000mg po single dose or 500 mg po daily for 3 days Trimethoprim-sulfamethoxazole (co-trimoxazole): 800/160mg po 12-hrly (one double strength tablet BD) If patient cannot tolerate orally: Ceftriaxone 1-2g i.v. for 5-days |
| Rationale | Local epidemiology |
| Level of evidence | High |